Compare BNR & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | NNOX |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 155.6M |
| IPO Year | 2019 | 2019 |
| Metric | BNR | NNOX |
|---|---|---|
| Price | $15.00 | $1.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 12.6K | ★ 1.6M |
| Earning Date | 06-05-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $111.65 | $147.55 |
| Revenue Next Year | N/A | $81.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $1.59 |
| 52 Week High | $41.72 | $5.72 |
| Indicator | BNR | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 34.47 | 46.82 |
| Support Level | $7.99 | $1.63 |
| Resistance Level | $22.50 | $1.88 |
| Average True Range (ATR) | 0.88 | 0.10 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 1.67 | 71.86 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.